2001 Quarterly Earnings Reports
Pharmaceutical Sector Companies
Updated 09/12/03
Current publicly reported financial results (in $millions) for pharmaceutical-based companies. Please note that all figures may reflect non-recurring charges, credits, gains or losses. Company fiscal years may not run according to the calendar year. Earnings will be updated as Network Science receives the data.
| Q1 | Q2 | Q3 | Q4 | YTD | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | Income | Revenue | Income | Revenue | Income | Revenue | Income | Revenue | Income | |
| Abbott (ABT) | $3,559.9 | ($223.6) | $4,099.1 | $529.1 | $4,181.2 | $631.4 | $4,445.1 | $613.6 | $16,285.2 | $1,550.5 |
| American Home (AHP) | $3,417.3 | $733.6 | $3,183.4 | $477.0 | $3,669.6 | $252.1 | $3,683.5 | $822.7 | $13,953.8 | $2,285.4 |
| AstraZeneca | $3,991.0 | $783.0 | $4,099.0 | $686.0 | $3,950.0 | $711.0 | $4,366.0 | $726.0 | $16,222.0 | $2,906.0 |
| Aventis (In Euros) | 5,865.0 | 317.0 | 5,780.0 | 413.0 | 5,356.0 | 391.0 | 5,939.0 | 384.0 | 22,941.0 | 1,505.0 |
| Bayer (in Euros) | 7,901.0 | 442.0 | 8,071.0 | 564.0 | 6,931.0 | (183.0) | 7,372.0 | 145.0 | 30,275.0 | 968.0 |
| Bristol-Myers Squibb (BMS) | $4,689.0 | $1,336.0 | $4,709.0 | $1,201.0 | $4,743.0 | $1,245.0 | $4,946.0 | $1,160.0 | $17,987.0 | $4,834.0 |
| Eli Lilly (LLY) | $2,805.7 | $806.8 | $3,033.5 | $827.7 | $2,874.0 | $570.1 | $2,828.9 | $575.4 | $11,542.1 | $2,780.0 |
| GlaxoSmithKline | $6,898.0 | $996.0 | $7,328.0 | $1,460.0 | $7,191.0 | $536.0 | $8,087.0 | $1,405.0 | $24,775.0 | $6,311.0 |
| Hoffmann-La Roche | 14,451.00 | 2,520.00 | 14,694.00 | 1,180.00 | 29,145.00 | 3,700.00 | ||||
| ICN Pharmaceuticals (ICN) | $199.0 | $21.0 | $204.4 | $21.3 | $182.4 | ($11.7) | $262.3 | $33.6 | $848.1 | $64.1 |
| Johnson & Johnson (JNJ) | $7,855.0 | $1,552.0 | $8,179.0 | $1,482.0 | $8,058.0 | $1,529.0 | $8,225.0 | $1,105.0 | $32,317.0 | $5,668.0 |
| Merck (MRK) | $11,345.1 | $1,657.3 | $11,893.1 | $1,815.4 | $11,919.6 | $1,948.2 | $12,558.0 | $1,860.9 | $47,715.8 | $7,281.8 |
| Novartis | 7,224.00 | 1,485.00 | 8,043.00 | 2,244.00 | 8,117.00 | 1,683.00 | 8,259.00 | 1,612.00 | 31,643.00 | 7,024.00 |
| Pfizer (PFE) | $7,584.0 | $1,930.0 | $7,622.0 | $1,829.0 | $7,824.0 | $2,072.0 | $8,180.0 | $1,956.0 | $29,024.0 | $7,787.0 |
| Pharmacia Corp | $3,210.0 | $250.0 | $3,301.0 | $737.0 | $4,466.0 | $428.0 | $3,684.0 | $476.0 | $13,835.0 | $1,901.0 |
| Schering-Plough (SGP) | $2,306.0 | $564.0 | $2,618.0 | $634.0 | $2,377.0 | $601.0 | $2,471.0 | $143.0 | $9,772.0 | $1,942.0 |
| Totals | $57,860.0 | $10,406.1 | $60,269.5 | $11,699.4 | $61,435.8 | $10,512.1 | $63,736.7 | $10,877.2 | $234,277.0 | $45,310.7 |
